Position in FDMT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,486,955
+$4,302,620 QoQ
Shares Held
562,929
+64.6% QoQ
Ownership
0.780%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,811,269,626 across 424 Biotechnology names. FDMT ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,486,955 | 562,929 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,184,335 | 342,034 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,353,650 | 313,820 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,916,241 | 335,586 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,220,496 | 328,975 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,230,370 | 380,920 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,454,503 | 440,665 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,655,682 | 430,683 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,713,383 | 367,479 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $11,921,436 | 374,182 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,401,848 | 365,343 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,630,217 | 363,725 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,005,871 | 332,367 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,717,433 | 274,429 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,103,773 | 274,821 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,224,506 | 276,680 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,914,828 | 274,331 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,920,311 | 259,280 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,580,920 | 254,372 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,119,579 | 189,825 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,372,553 | 98,528 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,780,262 | 87,143 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||